Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MAG | P20916 | 2/20 | 0.34 |
| ▸ | SELL | P14151 | 1/20 | 0.34 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
| ▸ | CD22 | P20273 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28733258 | 1.00 | NANP (0.62) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL29462899 | 1.00 | NANP (0.62) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL6046362 | 0.92 | NANP (0.59) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL28733265 | 0.92 | NANP (0.59) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL13190998 | 0.92 | NANP (0.59) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL29569418 | 0.92 | NANP (0.59) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL420656 | 0.91 | NANP (0.67) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL13190787 | 0.91 | NANP (0.67) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL29390472 | 0.91 | NANP (0.67) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL29632786 | 0.91 | NANP (0.67) | NANPL3MBTL1MAGSELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024221373-A1 | COSMETIC COMPOSITION AND USE THEREOF | L'OREAL (FR) | 2024-10-31 | — | — | WO | claimed |
| US-20220288095-A1 | SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS | LIFESCIENCE AS (NO) | 2022-09-15 | — | — | US | claimed |
| US-20260083762-A1 | SIALIC ACID COMPOSITIONS FOR THE USE OF INHIBITING AND TREATING CORONAVIRUS INFECTION | LIFESCIENCE AS (NO) | 2026-03-26 | — | — | US | disclosed |
| US-12390481-B2 | Sialic acid compositions for the use of inhibiting and treating coronavirus infection | LIFESCIENCE AS (NO) | 2025-08-19 | — | — | US | disclosed |
| US-20250057862-A1 | SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING INFECTIONS IN FISH | LIFESCIENCE AS (NO) | 2025-02-20 | — | — | US | disclosed |
| WO-2024221373-A1 | COSMETIC COMPOSITION AND USE THEREOF | L'OREAL (FR) | 2024-10-31 | — | — | WO | disclosed |
| US-20240190912-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINING MOLECULES USING THE SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-06-13 | — | — | US | disclosed |
| US-20240190913-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINING MOLECULES USING THE SAME | DONALDSON COMPANY, INC. | 2024-06-13 | — | — | US | disclosed |
| US-20240148763-A1 | SIALIC ACID COMPOSITIONS FOR THE USE OF INHIBITING AND TREATING CORONAVIRUS INFECTION | LIFESCIENCE AS (NO) | 2024-05-09 | — | — | US | disclosed |
| WO-2023111689-A1 | SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING INFECTIONS IN FISH | LIFESCIENCE AS (NO) | 2023-06-22 | — | — | WO | disclosed |
| US-20220288095-A1 | SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS | LIFESCIENCE AS (NO) | 2022-09-15 | — | — | US | disclosed |
| EP-2704597-B1 | PERFORMANCE ENHANCING COMPOSITIONS AND METHODS OF USE | LIFE SCIENCE NUTRITION AS (NO) | 2021-04-07 | — | — | EP | disclosed |
| US-10259833-B2 | Natural lipids containing non-oxidizable fatty acids | BERGEN TEKNOLOGIOVERFØRING AS (NO) | 2019-04-16 | — | — | US | disclosed |
| US-20180030073-A1 | NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS | NOBESITA AS (NO) | 2018-02-01 | — | — | US | disclosed |
| US-20160024125-A1 | NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS | BERGEN TEKNOLOGIOVERFØRING AS (NO) | 2016-01-28 | — | — | US | disclosed |
| US-20060218670-A1 | Compositions and methods for production of sialylated glyoproteins in plants | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2006-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030073-A1 | NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS | FASN, ELOVL1, FADS1 | NANP 539/4885L3MBTL1 3842/4885MAG 986/4885 |
| US-20250057862-A1 | SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING INFECTIONS IN FISH | SIGLEC9, SIGLEC7, NEU3 | NANP 16/4885L3MBTL1 2053/4885MAG 190/4885 |
| US-20240190913-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINING MOLECULES USING THE SAME | MGAM, MASP2, MGAM2 | NANP 282/4885L3MBTL1 4034/4885MAG 315/4885 |
| US-20160024125-A1 | NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS | FASN, ELOVL1, FADS1 | NANP 539/4885L3MBTL1 3842/4885MAG 986/4885 |
| US-20260083762-A1 | SIALIC ACID COMPOSITIONS FOR THE USE OF INHIBITING AND TREATING CORONAVIRUS INFECTION | NEU2, NEU1, SIGLEC9 | NANP 32/4885L3MBTL1 4162/4885MAG 715/4885 |
| US-10259833-B2 | Natural lipids containing non-oxidizable fatty acids | FASN, ELOVL1, FADS1 | NANP 539/4885L3MBTL1 3842/4885MAG 986/4885 |
| US-20240190912-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINING MOLECULES USING THE SAME | MGAM, CA14, MASP2 | NANP 357/4885L3MBTL1 3910/4885MAG 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.